124 related articles for article (PubMed ID: 3500235)
1. Production, assay and partial characterization of guinea pig interleukin 2.
Martensen H; Hasløv K; Mansa B; Bentzon MW
J Immunol Methods; 1987 Nov; 104(1-2):209-17. PubMed ID: 3500235
[TBL] [Abstract][Full Text] [Related]
2. Biological activities of guinea pig mitogenic factor from immune lymphocytes stimulated with antigen.
Iribe H; Koga T
Microbiol Immunol; 1983; 27(1):65-74. PubMed ID: 6602933
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a low molecular weight suppressor of lymphocyte proliferation from guinea pig L2C leukemia cells.
Collins DP; Cook DJ; Ricardo MJ
Cell Immunol; 1987 Apr; 105(2):397-410. PubMed ID: 3494530
[TBL] [Abstract][Full Text] [Related]
4. Lymphokines. I. Use of insoluble concanavalin A for the production of migration inhibitory factor in guinea pig lymphocyte cultures.
Friedrich W; Lazary S; Geczy C; de Weck AL
Int Arch Allergy Appl Immunol; 1975; 49(4):504-18. PubMed ID: 1099010
[TBL] [Abstract][Full Text] [Related]
5. Studies on thymocyte subpopulations in guinea pigs. VII. Characterization of cell populations responsive to guinea pig interleukin 1 and interleukin 2.
Sandberg G; Söder O; Tjernberg J
Immunobiology; 1985 Dec; 170(5):448-59. PubMed ID: 3879237
[TBL] [Abstract][Full Text] [Related]
6. Altered gene transcription after burn injury results in depressed T-lymphocyte activation.
Horgan AF; Mendez MV; O'Riordain DS; Holzheimer RG; Mannick JA; Rodrick ML
Ann Surg; 1994 Sep; 220(3):342-51; discussion 351-2. PubMed ID: 8092900
[TBL] [Abstract][Full Text] [Related]
7. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
8. Characterization of fibroblast proliferation factors elaborated by antigen- and mitogen-stimulated guinea pig lymph node cells: differentiation from lymphocyte-derived chemotactic factor for fibroblasts, lymphocyte mitogenic factor, and interleukin 1.
Postlethwaite AE; Kang AH
Cell Immunol; 1982 Oct; 73(1):169-78. PubMed ID: 6217901
[No Abstract] [Full Text] [Related]
9. Immunologic function of endothelial cells: guinea pig aortic endothelial cells support mitogen-induced T lymphocyte activation, but do not function as antigen-presenting cells.
Roska AK; Johnson AR; Lipsky PE
J Immunol; 1984 Jan; 132(1):136-45. PubMed ID: 6197441
[TBL] [Abstract][Full Text] [Related]
10. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
Duncan MR; George FW; Hadden JW
J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
[TBL] [Abstract][Full Text] [Related]
11. Identification of a membrane antigen that is distinct from the interleukin 2 receptor and that may be required for interleukin 2-driven proliferative responses.
Malek TR; Robb RJ; Shevach EM
J Immunol; 1983 Feb; 130(2):747-55. PubMed ID: 6184403
[TBL] [Abstract][Full Text] [Related]
12. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
Tadmori W; Reed JC; Nowell PC; Kamoun M
J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous production of a suppressor factor by a human macrophage-like cell line U937. II. Suppression of antigen- and mitogen-induced blastogenesis, IL 2 production and IL 2 receptor expression in T lymphocytes.
Fujiwara H; Toossi Z; Ohnishi K; Edmonds K; Ellner JJ
J Immunol; 1987 Jan; 138(1):197-203. PubMed ID: 3097146
[TBL] [Abstract][Full Text] [Related]
14. B cell increases and ex vivo IL-2 production as secondary endpoints for the detection of sensitizers in non-radioisotopic local lymph node assay using flow cytometry.
Jung KM; Jang WH; Lee YK; Yum YN; Sohn S; Kim BH; Chung JH; Park YH; Lim KM
Toxicol Lett; 2012 Mar; 209(3):255-63. PubMed ID: 22245253
[TBL] [Abstract][Full Text] [Related]
15. The production of vesicular stomatitis virus by antigen- or mitogen-stimulated lymphocytes and continuous lymphoblastoid lines.
Nowakowski M; Feldman JD; Kano S; Bloom BR
J Exp Med; 1973 Apr; 137(4):1042-59. PubMed ID: 4348276
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors regulate interleukin-2 synthesis of stimulated lymphocytes: consequence for production procedures.
Bödeker BG; Mühlradt PF
Dev Biol Stand; 1983; 55():247-54. PubMed ID: 6610588
[TBL] [Abstract][Full Text] [Related]
17. Surfactant associated protein-A inhibits human lymphocyte proliferation and IL-2 production.
Borron P; Veldhuizen RA; Lewis JF; Possmayer F; Caveney A; Inchley K; McFadden RG; Fraher LJ
Am J Respir Cell Mol Biol; 1996 Jul; 15(1):115-21. PubMed ID: 8679215
[TBL] [Abstract][Full Text] [Related]
18. Signals involved in T cell activation. II. Distinct roles of intact accessory cells, phorbol esters, and interleukin 1 in activation and cell cycle progression of resting T lymphocytes.
Davis L; Lipsky PE
J Immunol; 1986 May; 136(10):3588-96. PubMed ID: 3486215
[TBL] [Abstract][Full Text] [Related]
19. Swine interleukin 2 activity produced by mesenteric lymph node cells.
Iwata H; Ueda T; Takayanagi K; Wada M; Inoue T
J Vet Med Sci; 1993 Oct; 55(5):729-34. PubMed ID: 8286523
[TBL] [Abstract][Full Text] [Related]
20. A macrophage-derived factor that inhibits the production and action of interleukin 2.
Krakauer T
J Leukoc Biol; 1985 Sep; 38(3):429-39. PubMed ID: 3897422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
